MedTrace Logo

Effectiveness of Glucosamine + Chondroitin in Osteoarthrosis

NCT00860873 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2013-02-25

No results posted yet for this study

Summary

This study objective is to check the non-inferiority of the 2 formulations produced by EMS when compared with the same substances and pharmaceuticals forms of the product Condroflex (Zodiac), by promoting the relief of osteoarthrosis symptoms such as pain, stiffness and functional capacity that will be periodically measured by using the "Visual Analog Scale" of pain (VAS) and the questionnaire of Lequesne.

Conditions

  • Osteoarthrosis

Interventions

DIETARY_SUPPLEMENT

EMS Chondroitin Sulfate + Glucosamine Sulfate (Oral powder)

Chondroitin Sulfate 1200mg Glucosamine Sulfate 1500mg

DIETARY_SUPPLEMENT

EMS Chondroitin Sulfate 1200mg + Glucosamine Sulfate 1500mg (hard capsules)

Chondroitin Sulfate 1200mg Glucosamine Sulfate 1500mg

DIETARY_SUPPLEMENT

Zodiac: Chondroitin Sulfate 1200mg + Glucosamine Sulfate 1500mg (Oral powder)

Chondroitin Sulfate 1200mg + Glucosamine Sulfate 1500mg

DIETARY_SUPPLEMENT

Zodiac Chondroitin Sulfate 1200mg + Glucosamine Sulfate 1500mg (hard capsules)

Chondroitin Sulfate 1200mg + Glucosamine Sulfate 1500mg

Sponsors & Collaborators

  • Azidus Brasil

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2009-11-30
Completion
2010-11-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00860873 on ClinicalTrials.gov